Skip to main content Back to Top
Advertisement

1/7/2020

Meperidine Hydrochloride Injection

Products Affected - Description

    • Demerol injection, Pfizer, 100 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1180-69
    • Demerol injection, Pfizer, 100 mg/mL, 1 mL ampule, 25 count, NDC 00409-1256-01
    • Demerol injection, Pfizer, 100 mg/mL, 20 mL multiple dose vial, 1 count, NDC 00409-1201-20
    • Demerol injection, Pfizer, 25 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1176-30
    • Demerol injection, Pfizer, 50 mg/mL, 0.5 mL ampule, 25 count, NDC 00409-1203-01
    • Demerol injection, Pfizer, 50 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1178-30
    • Demerol injection, Pfizer, 50 mg/mL, 1 mL ampule, 25 count, NDC 00409-1253-01
    • Demerol injection, Pfizer, 50 mg/mL, 1.5 mL ampule, 25 count, NDC 00409-1254-01
    • Demerol injection, Pfizer, 75 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-1179-30
    • Meperidine injection, Hikma, 50 mg/mL, 1 mL vial, 25 count, NDC 00641-6053-25
    • Meperidine injection, ICU Medical, 10 mg/mL, 30 mL PCA glass vial, 10 count, NDC 00409-6030-04 - discontinued

Reason for the Shortage

    • Pfizer has Demerol injection on shortage due to manufacturing delays.
    • ICU Medical discontinued meperidine 30 mL PCA vials.

Available Products

    • Demerol injection, Pfizer, 50 mg/mL, 2 mL ampule, 25 count, NDC 00409-1255-02
    • Demerol injection, Pfizer, 50 mg/mL, 30 mL multiple dose vial, 1 count, NDC 00409-1181-30
    • Meperidine injection, Hikma, 100 mg/mL, 1 mL vial, 25 count, NDC 00641-6054-25
    • Meperidine injection, Hikma, 25 mg/mL, 1 mL vial, 25 count, NDC 00641-6052-25

Estimated Resupply Dates

    • Hikma has meperidine 50 mg/mL 1 mL vials on back order and the company estimates a release date of late-February 2020.
    • Pfizer has Demerol 25 mg/mL 1 mL Carpuject syringes, 50 mg/mL 1 mL Carpuject syringes, 75 mg/mL 1 mL Carpuject syringes, 100 mg/mL 1 mL Carpuject syringes, 50 mg/mL 1 mL and 1.5 mL ampules, and 100 mg/mL 1 mL ampules on back order and the company estimates a release date of August 2020. The 100 mg/mL 20 mL vials are on back order and the company estimates a release date of June 2020. The 50 mg/mL 0.5 mL ampules are available in limited supply.

Updated

Updated January 7, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 19, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins